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Abstract
The epithelial structures of the human breast or the mouse mammary gland are derived
from a relatively small number of multipotent, tissue-specific stem cells, of which we are
surprisingly ignorant. We do not know how many are required to produce a complete
mammary gland, how many times they divide during the process, where they are situated in
the gland, or even what they look like. We want to know the answers to these questions, not
just to satisfy intellectual curiosity, but also because the answers may shed light on the
evolution of breast cancer. Now, studies carried out by Kordon and Smith at the National
Cancer Institute have pointed the way toward a new understanding of mammary stem cells
and their progeny.
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Kordon and Smith [1] have refined a widely used model of
transplanting mouse mammary epithelium into the cleared
mammary fat pads of syngeneic or athymic nude mice [2],
and have shown that just one cell can give rise to a com-
plete and fully functional gland. To reach this remarkable
conclusion, Kordon and Smith took advantage of the
CzechII mouse strain. Like other strains, these mice
become infected congenitally with the mouse mammary
tumour virus (MMTV) through milk [3]. Unlike other
strains, however, the CzechII mice have no endogenous
MMTV-like sequences in their genome, so viral insertions
can be detected by Southern analysis as long as a large
enough number of cells contain the same insertion. The
only way that this can happen is if the population being
analyzed is clonal, and thus use of the CzechII mice repre-
sents an elegant advance on previous methods for detect-
ing transplanted populations in cleared mammary fat pads.
One cell, one mammary gland
Accordingly, Kordon and Smith [1] took small fragments
of mammary epithelium from CzechII MMTV-infected
mice and transplanted them into cleared mammary fat
pads of syngeneic hosts. These hosts were mated and 1
day after parturition about 80% of each of the reconsti-
tuted glands was removed for analysis, leaving the remain-
der intact for subsequent serial transplantation. As
expected, most of the transplanted epithelial fragments
expanded during pregnancy to become complete and
functional mammary glands. If these glands had been
derived from several different progenitors, no clear pattern
of MMTV-insertional events would have been detected.
If, on the other hand, the outgrowths were clonal a distinct
and easily detected pattern of MMTV insertion sites
would have been seen, as was the case in 20 of the 30 dif-
ferent outgrowths examined by Southern analysis. As aBreast Cancer Research    Vol 1 No 1 Anderson and Clarke
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control, the intact contralateral glands of the host mice
were analyzed in the same way and, as would be expected
for a polyclonal tissue derived from several progenitors, no
clear pattern of insertional events could be seen. The
inescapable conclusion of this first part of the work of
Kordon and Smith was that most of the reconstituted
mammary glands were clonal. Fragments of these clonal
glands were then transplanted into new hosts where they
were shown to retain the same pattern of MMTV insertion
sites, providing evidence of self-renewal of the original
stem cell. Additional MMTV insertion sites were often
detected, however, suggesting the acquisition of more
mutations during clonal expansion.
Two lineage-specific progenitors come from
one stem cell
The above work confirmed, very elegantly, what had been
strongly suspected but not proven – that the outgrowths
derived from transplantation of mammary epithelial frag-
ments are clonal in that they are the product of a single,
self-renewing stem cell. Because this progenitor gave rise
to fully functional outgrowths, we might have assumed
safely that it is multipotent. Nevertheless, Kordon and
Smith [1] decided to test this experimentally by trans-
planting limiting numbers of cells derived from third-gen-
eration outgrowths into cleared fat pads. These
outgrowths were first placed into primary culture to allow
accurate quantitation of the number of cells to be
implanted. Injection of 14000 cells into cleared fat pads
resulted in outgrowths in three out of eight cases, indicat-
ing that there was less than one clonogenic component per
injection. Only one of the three outgrowths completely
filled the fat pad with a lactating ductolobular structure,
however. The other two showed limited growth and one
was composed of primitive ducts, whereas the other com-
prised lobules. These results support previous studies by
Chepko and Smith [4] by suggesting the presence of a
single multipotent stem cell that gives rise to two lineage-
specific progenitors of a more limited proliferative capac-
ity. These lineage-specific progenitors might also be
considered multipotent or at the very least oligopotent
because they appear to be the precursors of both luminal
epithelial and myoepithelial cells. An interesting corollary
was that lineage-specificity must be an intrinsic property
because the limiting dilution experiments were carried
out under hormonal conditions (i.e. pregnancy) that are
known to support both ductal and lobular development,
but only one type or the other was achieved.
The final part of the studies of Kordon and Smith [1] com-
prised estimation of the number of cells that could be
derived from a single progenitor. This was achieved by
measuring the total DNA content of fat pads bearing lac-
tating outgrowths and then determining the proportion
contributed by the epithelial component. Using 6pg as
the DNA content of a single diploid mouse cell [5],
Kordon and Smith arrived at a range of 23–77×106 epithe-
lial cells per lactating outgrowth. Extrapolation of these
data indicated that a single cell would have to undergo
25–27 doublings to produce a lactating outgrowth. In prac-
tice, the number of doublings required was probably
rather less than this. In previous experiments [6], Smith
estimated that the number of stem cells capable of repop-
ulating a mammary fat pad was about 1 in 2500 of all
mammary epithelial cells. If the population dynamics
were the same in the clonal outgrowths as in the normal
gland, then the single progenitor would have undergone
self-renewal by symmetrical mitosis 11 times to produce
an equivalent number of stem cells which, in turn, would
contribute to repopulation of the fat pad.
Stem cells have prodigious proliferative
capacity
Mammary epithelial outgrowths become senescent after
approximately four serial transplants [7] meaning that the
original stem cell could undergo a total of 40–50 dou-
blings. Rather satisfyingly, this figure agrees with the
‘Hayflick number’ (i.e. the maximum number of divisions
a eukaryotic cell can undergo before replicative senes-
cence occurs [8]). This also makes it clear that stem cells
have prodigious proliferative capacity; just one cell could
give rise to a further 1012–1013 multipotent progenitors
during its lifetime. It is also clear, however, that no stem
cell in the mammary gland actually realizes this potential
within the lifetime of the mouse or woman. It appears that
the signals that initiate proliferation are very tightly regu-
lated so that, under normal circumstances, stem cells
cannot divide uncontrollably. These control mechanisms
are poorly understood, but one possibility is that stem cell
proliferative activity is influenced by position in relation
to more differentiated progeny, to the basement mem-
brane and to stromal cells. It is unclear what these ‘posi-
tional cues’ are, although we do know that division
competent cells in both the mouse mammary gland and
the human breast are separate from, but adjacent to cells
that express receptors for oestrogen, implying that this
steroid controls proliferation indirectly [9,10]. Transform-
ing growth factor-b is a prime candidate for the role of a
negative growth regulator secreted by differentiated
progeny surrounding the stem cells [11, 12].
Human breast development
Thus, through a combination of inspired experiments and
thoughtful interpretation of their data, Kordon and Smith
[1] have made considerable progress toward answering
some of our questions about stem cells. We now know that
just one stem cell can generate a complete mammary
gland, during which process it probably undergoes about
11 self-renewing symmetrical divisions to give rise to other
stem cells and the more committed, lineage-specific pre-
cursors. Along the way, evidence has been found to suggest
that lineage-specificity is intrinsic and that lineage-specific13
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precursors are oligopotent. What are the implications for
human breast development and the evolution of cancers?
Although there are important differences between the
mouse mammary gland and the human breast in terms of
the timing of maximal growth and differentiation, there is
evidence to suggest that the human breast epithelium is
derived also from multipotent stem cells scattered through-
out the ductal structure. This has been demonstrated most
clearly in studies in which contiguous patches of epithe-
lium were shown to be clonal in terms of their pattern of X-
chromosome inactivation [13]. We know that most human
hyperplasias and tumours arise from the luminal epithelial
population and that they are clonal [14,15], but we do not
know much more because of the lack of suitable in vitro or
in vivo models for the study of human breast epithelial
stem cells. It is to be hoped that results of studies on the
mouse mammary gland can be used to accelerate the
development of these, much needed, models.
Cancer prevention and treatment
As far as cancer is concerned, there is indirect evidence
that stem cells persist in the mammary gland throughout
life, where they must be regarded as prime targets for
oncogenic transformation. Perhaps it is time for us to adjust
our preconceptions as to exactly what is oncogenic transfor-
mation, however. The work of Kordon and Smith makes it
clear that immortalization is not necessary as a single prog-
enitor can already produce more than enough cells to kill
someone of breast cancer. Perhaps the earliest steps in
tumourigenesis are those that allow a stem cell to escape
from the constraints imposed by its position. Once escape
has been achieved, it seems highly likely that further
genetic alterations will accumulate as suggested by Kordon
and Smith after they demonstrated that additional MMTV
insertions occurred during clonal expansion. We can specu-
late that these further mutations might enhance sensitivity
to growth promoters such as oestrogen, switch on produc-
tion of angiogenic factors or confer metastatic potential.
Finally, it is clear that successful breast cancer treatment
or prevention strategies must eradicate stem cells. Most
current chemotherapeutic and endocrine agents induce
apoptosis, but whether mammary stem cells are suscepti-
ble to programmed cell death is not known. Studies on the
mouse small intestine suggest that there may be two pop-
ulations of stem cells. One of these undergoes sponta-
neous apoptosis as part of the homeostatic mechanism
restricting the number of stem cells present at any one
time [16]. The other, smaller, population is resistant to
radiation-induced apoptosis, undergoes DNA repair and,
presumably, is responsible for repopulation of the
damaged intestinal epithelium. The model of trans-
planted mouse mammary gland refined by Kordon and
Smith should allow us to determine whether mammary
stem cells exhibit similar properties and to develop the
means to overcome resistance to apoptosis.
Conclusion
We believe that the future of breast cancer research lies in
the elucidation of the mechanisms governing mammary
gland stem cell activity and numbers. Kordon and Smith
[1] have provided us with an important new tool for study-
ing clonal populations and the stem cells from which they
are derived. We now need to apply ourselves to the
exhaustive study of the ontogeny and biology of human
breast stem cells that they recommended.
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